Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
Cancers|March 28, 2026
End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab BetaEvelyn R Lu, Calvin P L Hoo, Ho Ming Cheung, et al.
Acta Neuropathologica|December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Neuro-Oncology|July 29, 2024
SNO-EANO-EURACAN consensus on management of pineal parenchymal tumorsAnthony P Y Liu, Bryan K Li, Alexandre Vasiljevic, et al.
Cancers|October 14, 2023
Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong KongOtto C H Tam, Ronnie S L Ho, Shing Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 25, 2020
Clinical Outcomes and Complications of Pituitary BlastomaAnthony P Y Liu, Megan M Kelsey, Nelly Sabbaghian, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 29, 2020
[Evaluation of the emergency response strategies and measures on the epidemic of COVID-19 in Shenzhen, China]X Zou, Y S Wu, X J Liu, et al.
Acta Neuropathologica Communications|November 21, 2024
High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumorsYoshiko Nakano, Ian Burns, Liana Nobre, et al.
BMC Medical Genomics|October 26, 2018
Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES)Gordon K C Leung, Christopher C Y Mak, Jasmine L F Fung, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumoursAya El Helali, Tai-Chung Lam, Elaine Yee-Ling Ko, et al.
Pageof 30